John Ransom
Stock Analyst at Raymond James
(4.59)
# 219
Out of 5,090 analysts
205
Total ratings
65.45%
Success rate
15.8%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $15.47 | +93.92% | 10 | Oct 3, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $78.59 | -4.57% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $9.31 | -3.33% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $75.90 | +18.58% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $210.00 | -4.76% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $265.44 | +45.04% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $330.91 | +63.19% | 13 | Apr 21, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $486.70 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.57 | - | 8 | Nov 22, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $2.71 | +269.00% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $112.50 | -15.56% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $257.85 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $16.77 | +19.26% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $20.29 | +47.86% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $19.55 | -38.62% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $75.63 | +12.39% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $113.19 | -7.24% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $3.04 | +228.95% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.60 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $36.93 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $24.26 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $117.39 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.19 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $15.47
Upside: +93.92%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $78.59
Upside: -4.57%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $9.31
Upside: -3.33%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $75.90
Upside: +18.58%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $210.00
Upside: -4.76%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $265.44
Upside: +45.04%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $330.91
Upside: +63.19%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $486.70
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.57
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $2.71
Upside: +269.00%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $112.50
Upside: -15.56%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $257.85
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $16.77
Upside: +19.26%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $20.29
Upside: +47.86%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $19.55
Upside: -38.62%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $75.63
Upside: +12.39%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $113.19
Upside: -7.24%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $3.04
Upside: +228.95%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.60
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $36.93
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $24.26
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $117.39
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $17.19
Upside: -